IBC Life Sciences

TIDES ® 2010

Firoz D. Antia, Ph.D., Executive Director, Product Development, Palatin Technologies, Inc.

Neil H. Baine, Ph.D., Executive Director, Scinovo, Preclinical Development, GlaxoSmithKline Pharmaceuticals

Bob D. Brown, Ph.D., Senior Vice President, Research, Dicerna Pharmaceuticals, Inc.

Daniel Capaldi, Ph.D., Vice President, Analytical and Process Development, Isis Pharmaceuticals, Inc.

Gary Carter, Business Development Manager, Nucleic Acids Solutions Division, Agilent Technologies Inc.

Hagen Cramer, Ph.D., Oligonucleotide Process Development Section Head, Girindus America Inc. Member of Solvay Organics

Masad J. Damha, Ph.D., F.C.I.C., James McGill Professor of Chemistry, McGill University, Canada

Jesse Z. Dong, Ph.D., Vice President, Chemistry, Ipsen

Peter Hoffmann, Ph.D., Vice President, New Technology Development, Genzyme Pharmaceuticals

Christopher P. Holmes, Ph.D., Executive Director, Chemistry, Affymax, Inc.

Rob Johnson, Director, Analytical and Chemical Development, Amylin Pharmaceuticals, Inc.

Troels Koch, Ph.D., Vice President and CTO, Santaris Pharma A/S, Denmark

Arthur M. Krieg, M.D., Chief Scientific Officer, Research Technology Center, Pfizer Inc.

Tim Lannan, Senior Manager, Global Manufacturing Services, Pfizer Inc.

Rodney Lax, Director, Business Development, PolyPeptide Laboratories, Inc.

Derek Maclean, Director, Chemistry, Kai Pharmaceuticals

Bing Mao, Ph.D., Associate Director, Process Research, Merck & Co., Inc.

John P. Mayer, Ph.D., Senior Research Advisor, Eli Lilly and Co.

Gary F. Musso, Ph.D., President, Musso and Associates LLC

Lubomir V. Nechev, Ph.D., Senior Director, Process Chemistry, Alnylam Pharmaceuticals, Inc.

Rodney Parsons, Ph.D., Director, Process R&D, Bristol-Myers Squibb

Christopher A. Rhodes, Ph.D., Executive Director, Pharmaceutical Sciences, Amylin Pharmaceuticals, Inc.

Stephen Sofen, Ph.D., Vice President, CMC Project/Product Management, Genzyme Corporation

G. Susan Srivatsa, Ph.D., President, ElixinPharma

James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, Quark Pharmaceuticals, Inc.

David Tumelty, Ph.D., Associate Director, Chemistry, BioTherapeutics R&D, Pfizer Inc.

Fran Wincott, Ph.D., President, Wincott & Associates, LLC

Emma Wright, Ph.D., Director, Process Development, Avecia OligoMedicines

Applications of Nucleic Acids Technologies in Molecular Diagnostics

Thomas Battersby, Ph.D., Senior Manager, Siemens Healthcare Diagnostics

Michael Christopherson, Ph.D., Group Leader, Oligonucleotide Manufacturing, Roche Molecular Systems

B. Melina Cimler, Ph.D., Senior Vice President, Government Affairs, Beckman-Coulter Inc.

Dick Keys, Ph.D., Bioorganic Chemistry, Diagnostics Technology Manager

Marc Lemaitre, Ph.D., CEO, Girindus America Inc. - Member of Solvay Organics

Stefan Matysiak, Ph.D., Principal Consultant, General BioArrays Consulting, US and Germany

Diane Wolfe, General Manager, Eurogentec North America, Inc.